{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2018:UEEFMPCFQEYC3BIJDDDNBLKNJ3","short_pith_number":"pith:UEEFMPCF","canonical_record":{"source":{"id":"1806.08807","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-06-22T18:16:57Z","cross_cats_sorted":[],"title_canon_sha256":"fc3a8032c38b216b18660e8a8b45a0229849d0b328e5bd0c4f50e3d5e7937495","abstract_canon_sha256":"3ebf7a8035577249129af91a4e86b2a6bb1a7a546fe6f0e720164cd6473546b2"},"schema_version":"1.0"},"canonical_sha256":"a108563c4581302d850918c6d0ad4d4ee4a15704caf03a169b4354ffe83c2a4a","source":{"kind":"arxiv","id":"1806.08807","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1806.08807","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"arxiv_version","alias_value":"1806.08807v1","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1806.08807","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"pith_short_12","alias_value":"UEEFMPCFQEYC","created_at":"2026-05-18T12:32:56Z"},{"alias_kind":"pith_short_16","alias_value":"UEEFMPCFQEYC3BIJ","created_at":"2026-05-18T12:32:56Z"},{"alias_kind":"pith_short_8","alias_value":"UEEFMPCF","created_at":"2026-05-18T12:32:56Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2018:UEEFMPCFQEYC3BIJDDDNBLKNJ3","target":"record","payload":{"canonical_record":{"source":{"id":"1806.08807","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-06-22T18:16:57Z","cross_cats_sorted":[],"title_canon_sha256":"fc3a8032c38b216b18660e8a8b45a0229849d0b328e5bd0c4f50e3d5e7937495","abstract_canon_sha256":"3ebf7a8035577249129af91a4e86b2a6bb1a7a546fe6f0e720164cd6473546b2"},"schema_version":"1.0"},"canonical_sha256":"a108563c4581302d850918c6d0ad4d4ee4a15704caf03a169b4354ffe83c2a4a","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:12:31.223307Z","signature_b64":"eU0sf/hiF/N2yf3JHujS1U6LWuZMJdpOj34R9mBPtUO7wpNF6s0gPVI39+O9F8HRLvrQ1319F4eSWcYhZwjdDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"a108563c4581302d850918c6d0ad4d4ee4a15704caf03a169b4354ffe83c2a4a","last_reissued_at":"2026-05-18T00:12:31.222710Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:12:31.222710Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1806.08807","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:12:31Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"wIf37TRMrj0Hvw4ZrwIjGAnDbMc/UxSsA0sinbbfbrgZ+iaJfpnBOZUtsqnhC0bShx6RRA6ddW6e6Mxwj0ASCw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-20T15:17:40.074339Z"},"content_sha256":"b0548c1c1305a6fef94a5ef27080d341087a5442037140ed67cff6ee0841f884","schema_version":"1.0","event_id":"sha256:b0548c1c1305a6fef94a5ef27080d341087a5442037140ed67cff6ee0841f884"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2018:UEEFMPCFQEYC3BIJDDDNBLKNJ3","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Estimating the treatment effect in a subgroup defined by an early post-baseline biomarker measurement in randomized clinical trials with time-to-event endpoint","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Bj\\\"orn Bornkamp, Georgina Bermann","submitted_at":"2018-06-22T18:16:57Z","abstract_excerpt":"Biomarker measurements can be relatively easy and quick to obtain and they are useful to investigate whether a compound works as intended on a mechanistic, pharmacological level. In some situations, it is realistic to assume that patients, whose post-baseline biomarker levels indicate that they do not sufficiently respond to the drug, are also unlikely to respond on clinically relevant long term outcomes (such as time-to-event). However the determination of the treatment effect in the subgroup of patients that sufficiently respond to the drug according to their biomarker levels is not straight"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1806.08807","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:12:31Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"hsTPkCoPGowjzcJc3LQTUP93OFZZCIFszcdIuanY7rNNQ5103SWZdBgl5njhUSDHpt7wmLfAqBnxVHj2aEQoDQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-20T15:17:40.074686Z"},"content_sha256":"7b28117e5ba90678905a0e4222fe61ce612d886a9805a30c2abf1299c87f0b41","schema_version":"1.0","event_id":"sha256:7b28117e5ba90678905a0e4222fe61ce612d886a9805a30c2abf1299c87f0b41"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/bundle.json","state_url":"https://pith.science/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-20T15:17:40Z","links":{"resolver":"https://pith.science/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3","bundle":"https://pith.science/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/bundle.json","state":"https://pith.science/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/state.json","well_known_bundle":"https://pith.science/.well-known/pith/UEEFMPCFQEYC3BIJDDDNBLKNJ3/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2018:UEEFMPCFQEYC3BIJDDDNBLKNJ3","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"3ebf7a8035577249129af91a4e86b2a6bb1a7a546fe6f0e720164cd6473546b2","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-06-22T18:16:57Z","title_canon_sha256":"fc3a8032c38b216b18660e8a8b45a0229849d0b328e5bd0c4f50e3d5e7937495"},"schema_version":"1.0","source":{"id":"1806.08807","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1806.08807","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"arxiv_version","alias_value":"1806.08807v1","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1806.08807","created_at":"2026-05-18T00:12:31Z"},{"alias_kind":"pith_short_12","alias_value":"UEEFMPCFQEYC","created_at":"2026-05-18T12:32:56Z"},{"alias_kind":"pith_short_16","alias_value":"UEEFMPCFQEYC3BIJ","created_at":"2026-05-18T12:32:56Z"},{"alias_kind":"pith_short_8","alias_value":"UEEFMPCF","created_at":"2026-05-18T12:32:56Z"}],"graph_snapshots":[{"event_id":"sha256:7b28117e5ba90678905a0e4222fe61ce612d886a9805a30c2abf1299c87f0b41","target":"graph","created_at":"2026-05-18T00:12:31Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Biomarker measurements can be relatively easy and quick to obtain and they are useful to investigate whether a compound works as intended on a mechanistic, pharmacological level. In some situations, it is realistic to assume that patients, whose post-baseline biomarker levels indicate that they do not sufficiently respond to the drug, are also unlikely to respond on clinically relevant long term outcomes (such as time-to-event). However the determination of the treatment effect in the subgroup of patients that sufficiently respond to the drug according to their biomarker levels is not straight","authors_text":"Bj\\\"orn Bornkamp, Georgina Bermann","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-06-22T18:16:57Z","title":"Estimating the treatment effect in a subgroup defined by an early post-baseline biomarker measurement in randomized clinical trials with time-to-event endpoint"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1806.08807","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:b0548c1c1305a6fef94a5ef27080d341087a5442037140ed67cff6ee0841f884","target":"record","created_at":"2026-05-18T00:12:31Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"3ebf7a8035577249129af91a4e86b2a6bb1a7a546fe6f0e720164cd6473546b2","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2018-06-22T18:16:57Z","title_canon_sha256":"fc3a8032c38b216b18660e8a8b45a0229849d0b328e5bd0c4f50e3d5e7937495"},"schema_version":"1.0","source":{"id":"1806.08807","kind":"arxiv","version":1}},"canonical_sha256":"a108563c4581302d850918c6d0ad4d4ee4a15704caf03a169b4354ffe83c2a4a","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"a108563c4581302d850918c6d0ad4d4ee4a15704caf03a169b4354ffe83c2a4a","first_computed_at":"2026-05-18T00:12:31.222710Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:12:31.222710Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"eU0sf/hiF/N2yf3JHujS1U6LWuZMJdpOj34R9mBPtUO7wpNF6s0gPVI39+O9F8HRLvrQ1319F4eSWcYhZwjdDw==","signature_status":"signed_v1","signed_at":"2026-05-18T00:12:31.223307Z","signed_message":"canonical_sha256_bytes"},"source_id":"1806.08807","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:b0548c1c1305a6fef94a5ef27080d341087a5442037140ed67cff6ee0841f884","sha256:7b28117e5ba90678905a0e4222fe61ce612d886a9805a30c2abf1299c87f0b41"],"state_sha256":"1c55d7f7927d39b0b93fb2662a599090e3492ea4284bf7ec811ec8ea0c18f296"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"18NyYuH2FTjz4coMqUOGkUrQDcXB2GqlZpl4Bi1vCX0w1JrulOQShCe5bGI1/B5w06HPH95C0IMj4jGboAaVAg==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-20T15:17:40.076605Z","bundle_sha256":"cb46e3864fc06d1330156e7b4242c0a21810e2c0b13459eb2454e2ece5289608"}}